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Review article
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Abstract
Introduction: Informing children of their own HIV status is an important aspect of long-term disease management, yet there is
little evidence of how and when this type of disclosure takes place in resource-limited settings and its impact.
Methods: MEDLINE, EMBASE and Cochrane Databases were searched for the terms hiv AND disclos* AND (child* OR adolesc*).
We reviewed 934 article citations and the references of relevant articles to find articles describing disclosure to children and
adolescents in resource-limited settings. Data were extracted regarding prevalence of disclosure, factors influencing disclosure,
process of disclosure and impact of disclosure on children and caregivers.
Results: Thirty-two articles met the inclusion criteria, with 16 reporting prevalence of disclosure. Of these 16 studies,
proportions of disclosed children ranged from 0 to 69.2%. Important factors influencing disclosure included the child’s age and
perceived ability to understand the meaning of HIV infection and factors related to caregivers, such as education level, openness
about their own HIV status and beliefs about children’s capacities. Common barriers to disclosure were fear that the child would
disclose HIV status to others, fear of stigma and concerns for children’s emotional or physical health. Disclosure was mostly led
by caregivers and conceptualized as a one-time event, while others described it as a gradual process. Few studies measured the
impact of disclosure on children. Findings suggested adherence to antiretroviral therapy (ART) improved post-disclosure but the
emotional and psychological effects of disclosure were variable.
Conclusions: Most studies show that a minority of HIV-infected children in resource-limited settings know his/her HIV status.
While caregivers identify many factors that influence disclosure, studies suggest both positive and negative effects for children.
More research is needed to implement age- and culture-appropriate disclosure in resource-limited settings.
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Introduction
Of the 3.4 million children under the age of 15 years living
with HIV worldwide [1], almost 90% live in sub-Saharan Africa
[2]. Increasing numbers of these children have access to
antiretroviral therapy (ART) and improved prognoses for
survival [3]. This requires healthcare systems in resourcelimited settings to address challenges, such as maintaining
medication adherence, responding to the psychosocial
implications of HIV infection, life-skills training and supporting long-term disease management. As more of these
children reach adolescence and adulthood, another important challenge is determining how and when to inform
children about their HIV status [4,5].
One definition of disclosure refers to a child gaining
knowledge of his/her HIV status [6]. For the purposes of
this review, we focus on this type of disclosure, while
acknowledging paediatric disclosure can also refer to disclosure of caregivers’ HIV status to children [7,8] or a child’s
disclosure of their own HIV status to others [9,10]. Recommendations for disclosure in the United States endorse a

gradual process of giving children age-appropriate information regarding their illness, leading to full disclosure when the
child has the cognitive and emotional maturity to process
this information [4,6,11,12].
The effects of disclosure are not well studied. While some
studies from resource-rich settings show that disclosure is
associated with higher self-esteem, fewer symptoms of
depression, improved adherence and higher CD4 counts
[1317], other studies do not [1821]. Furthermore, many
studies to date have utilized cross-sectional designs and
cannot adequately assess the impact of disclosure on clinical
or psychosocial characteristics [6]. Other studies suggest that
HIV-infected children who know their status may be better
able to seek social support, have improved coping skills
[11,22] and practice safer sexual practices to prevent
secondary transmission [23,24].
Disclosure is crucial to long-term disease management
[12], yet how and when caregivers and healthcare professionals in resource-limited settings disclose to children are
not well-characterized and the number of children that know
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their status is generally thought to be low. Moreover, many
of these settings currently lack standardized, culturally
appropriate guidelines and resources for undertaking disclosure [25]. While organizations such as the World Health
Organization and Médecins Sans Frontières have published
recommendations for disclosure of HIV status to children,
they do not have a broad evidence base and are not contextspecific with considerations of different cultural views on
age, maturity and psychosocial development [2628]. This
systematic review aims to estimate the prevalence of
HIV disclosure among children in low- and middle-income
countries, to examine factors influencing paediatric disclosure, including barriers to and advantages of disclosure, and
to assess the impact of disclosure on children’s physical and
emotional health in these settings.

Methods
We searched several bibliographic databases, including
MEDLINE (January 1, 1966November 23, 2011), EMBASE
(InceptionOctober 30, 2011), Cochrane Central Register of
Controlled Trials (CENTRAL) (InceptionNovember 23, 2011)
and Cochrane Database of Systematic Reviews (Inception
November 23, 2011). We used the search strategy: hiv AND
disclos* AND (child* OR adolesc*). Two authors (RCV and
AMG) reviewed the titles of all returned articles to determine
which studies examined HIV status disclosure to children in
resource-limited settings. A structured data extraction tool
was used to evaluate all articles. Search terms were only
entered in English; articles written in English, French, Spanish,
or Portuguese were reviewed. Articles were immediately
excluded if they did not involve HIV disclosure, children or
adolescents, were not conducted in a resource-limited setting, or were not in English, French, Spanish, or Portuguese.
We also searched the bibliographies of the retrieved studies
and relevant review articles.
Two authors (RCV and AMG) independently reviewed the
articles to determine inclusion. Disagreements were resolved
by consensus. For inclusion, the study needed to describe
disclosure of HIV status to HIV-infected children or adolescents aged 18 years or less. In addition, the studies needed to
be conducted in a resource-limited setting, defined as a lowor middle-income country using the World Bank classification
[29]. Studies describing populations of HIV-infected individuals over 18 years of age were included if they also had data
on individuals younger than 18 years. Studies that focused
only on disclosure of the parent’s HIV status to children were
excluded, as were studies that focused on disclosure of a
child’s HIV status to community members, schools, or other
individuals, without disclosure to the child. Each article was
analyzed to determine the sample characteristics, study
setting, definition of and prevalence of disclosure, reasons
for and against disclosure, outcomes of disclosure, and the
process and method of disclosure.

Results
Studies of paediatric HIV disclosure in resource-limited
settings
The systematic literature search identified 934 articles (Figure
1). Once articles whose titles alone indicated that they did not

934 titles identified by
electronic searches
414 articles excluded on review of
titles and/or subject headings
520 abstracts reviewed and 2 additional
articles identified through bibliography
searches
490 articles excluded on review of
abstracts (did not include HIV disclosure,
children or were not conducted in
resource- limited setting)

32 articles met all search criteria and are
included in review

Figure 1. Flow diagram of phases of paediatric disclosure
systematic review.

address disclosure to HIV-infected children were excluded,
520 articles remained, for which abstracts and then full-text
articles were reviewed. Two additional studies were identified
through searches of bibliographies [30,31]. Thirty-two articles
met all search criteria and were included in this systematic
review.
From the thirty-two articles describing HIV disclosure to
paediatric patients in resource-limited settings, we extracted
data on the location, setting, sample size, study design, population characteristics and prevalence of disclosure (Table 1).
Two articles described the same study population [32,33] and
therefore were considered a single-study population for this
review; however, we make reference to both articles where
appropriate due to unique findings. Twenty-one of the studies
were conducted in Africa [30,32,3451] with the remaining
primarily from Asia and South America. Most studies relied on
small samples, with the largest two studies including 492 HIVinfected children and adolescents [48] and 390 caregivers
[44]. Eighteen studies used a qualitative study design including interviews or focus groups [30,32,34,35,37,3943,47,49,
5156]. Six studies included only children and adolescents
[17,31,48,50,53,57] and eight studies included only caregivers
(parents or guardians) [25,37,38,42,45,51,55,58]. Ten studies
included children and caregivers [30,36,40,41,44,49,52,54,
56,59], while seven studies also included healthcare professionals [32,34,35,39,43,46,47].
Some studies defined disclosure generally, using some
variant of the concept of children knowing their HIV status
[25,34,46,51,5658], while other studies used a more
stringent definition, considering disclosure to have occurred
only if there was confirmation that the terms ‘‘HIV’’ or ‘‘AIDS’’
had been used with or specifically mentioned by the child
[17,30,32,36,41,45,54,59]. Six studies required a child to have
been informed of their status before participating in the
study [32,35,40,41,56,57], ensuring that 100% of the sample
had been disclosed to, but eliminating the possibility of
providing an estimate of disclosure prevalence. Sixteen
studies reported proportions of disclosed children for their
study population [17,25,30,31,34,36,38,45,4852,54,58,59],
ranging from 0 to 69.2%. Few studies included appropriate
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Study characteristics
Children’s age range

Study
Abadia-Barrero

Title
The disclosure model versus a

Location
Sao Paulo,

and Larusso,

developmental illness experience model for Brazil

2006

children and adolescents living with HIV/

Arun et al., 2009
Bhattacharya
et al., 2010

AIDS in Sao Paulo, Brazil
Disclosure of the HIV infection status in

New Delhi,

children

India

Patterns of diagnosis disclosure and its

Northern

correlates in HIV-infected North Indian

India

Setting

Study design

Population

Sample size (N)

and/or mean or

Proportions of

median age (SD)

disclosed children

Home

Qualitative

Children

36

115 years

N/A

Hospital

Qualitative

Caregivers

50

Mean: 8.98 (0.42)

14%

Hospital

Cross-

Caregiver-child

290 (145 children,

5 years; mean: 9.1

sectional

dyads

145 caregivers)

(2.5)

Qualitative

Caregivers, health

26 (12 caregivers, 14 114 years; mean:

professionals

health professionals) 8.52 (2.97)

Cross-

Caregiver-child

780 (390 children,

114 years; mean:

17.4% (by age: 5.9%

sectional

dyads

390 caregivers)

8.52 (2.97)

05 years, 41.2% 69

41.4%

children
Biadgilign et al.,
2009

Barriers and facilitators to antiretroviral

Addis Ababa,

Hospital

medication adherence among HIV-infected Ethiopia

N/A

paediatric patients in Ethiopia: a
qualitative study
Biadgilign et al.,
2011

Factors associated with HIV/AIDS

Addis Ababa,

diagnostic disclosure to HIV infected

Ethiopia

Hospital

children receiving HAART: a multi-center

years, 52.9% 1014

study in Addis Ababa, Ethiopia
Bikaako-Kajura
et al., 2006
Boon-Yashidi
et al., 2005

years)

Disclosure of HIV status and adherence to Kampala,
daily drugs regimens among HIV-infected

Uganda

children in Uganda
Diagnosis disclosure in HIV-infected Thai

Bangkok,

Children

Thailand

Clinic

Hospital

Qualitative

Qualitative

Caregiver-child

84 (42 children and

517 years; median:

29% complete

dyads

42 caregivers)

12

parental disclosure,

Children and

115 (19 children, 96

38% partial disclosure
515 years; mean: 9.6 19.8% (in sample of

caregivers

caregivers)

96 children. Only
disclosed sample  19
children  were
included in qualitative
analysis)

Brown et al., 2011 Disclosure of HIV status to infected children Ibadan,
*Corneli et al.,
2009

Clinic

in a Nigerian HIV care programme
Nigeria
The role of disclosure in relation to assent Kinshasa, DRC Clinic

Crosssectional
Qualitative

Caregivers

96

614 years; mean: 8.8

13.5%

(2.2)
1121 years; median:

N/A

Children,

72 (19 children, 36

to participate in HIV-related research

caregivers, health

caregivers, 17 health 16

among HIV-infected youth: a formative

professionals

professionals)

study
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Study
De Baets et al.,
2008

Demmer, 2011

Feinstein et al.,
2010

Title

Location

Setting

Study design

Population

Hospital and Qualitative

Health

195 (64 health

with Shona children: a comparison

clinic

professionals,

professionals, 131

between healthcare workers and
community members in Eastern Zimbabwe
Experiences of families caring for an HIV- KwaZulu-

Clinic and

infected child in KwaZulu-Natal, South

home

Natal, South

Africa: an exploratory study

Africa

Effect of disclosure on HIV status to

Soweto,

children receiving ART on six-month

South Africa

Unspecified

Qualitative

Prospective

Proportions of

median age (SD)

disclosed children

Sample size (N)

HIV disclosure and discussions about grief Eastern
Zimbabwe

Children’s age range
and/or mean or

Not reported

N/A

community

community

members
Caregivers, health

members)
25 (13 caregivers, 12 Not reported

N/A

professionals

health professionals)

Children

492

418 years

cohort

3% (children aged
46 years); 17%

virologic suppression

(children aged 710
years); 77% (children

Ferris et al., 2007 The influence of disclosure of HIV diagnosis Constanta,

Clinic

on time to disease progression in a cohort Romania

Retrospective

Children

325

cohort

517 years; mean:

]11 years)
69.2%

13.5 (1.5)

of Romanian children and teens
Fetzer et al., 2011 Barriers to and facilitators of adherence to Kinshasa, DRC Hospital

Qualitative

pediatric antiretroviral therapy in a sub-

Caregiver-child

40 (20 children, 20

917 years; median:

dyads

caregivers)

14

20.0%

Saharan setting: insights from a qualitative
study
Haberer et al.,
2011

Excellent adherence to antiretrovirals in
Lusaka,
HIV Zambian children is compromised by Zambia

Clinic and
home

Prospective
cohort

Hospital

Qualitative

Children

96

Median 6 (IQR 2, 9)

2.0%

818 years

N/A

disrupted routine, HIV nondisclosure, and
Hejoaka, 2009

paradoxical income effects
Care and secrecy: being a mother of

Burkina Faso

children living with HIV in Burkina Faso
Kallem et al.,

Prevalence and pattern of disclosure of HIV Accra, Ghana

2010
Kouyoumdjiam

status in HIV-infected children in Ghana
Barriers to disclosure to children with HIV Soweto,

et al., 2005
Lee and
Oberdorfer,
2009

Children,

57 (15 children, 20

caregivers, health

caregivers, 22 health

professionals

professionals)

Hospital

Cross-

Caregiver-child

142 (71 children, 71

814 years; mean:

21%

Clinic

sectional
Qualitative

dyads
Caregivers

caregivers)
17

10.42 (1.72)
Not reported

N/A

Hospital

Qualitative

Children

] 13 years; median

N/A

South Africa
Risk-taking behaviors among vertically HIV- Northern
infected adolescents in northern Thailand

Thailand

54

14.6 (IQR 13.8, 16.1)
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Study
Marques et al.,
2006

Title
Disclosure of HIV infection from the

Location

Setting

Sao Paulo and Clinic

Study design
Qualitative

perspective of adolescents living with HIV/ Santos, Brazil

Population

Sample size (N)

Children,

46 (22 children,

caregivers

24 caregivers)

Children’s age range
and/or mean or

Proportions of

median age (SD)

disclosed children

1020 years

N/A

AIDS and their parents and caregivers
Menon et al.,
2007

Mental health and disclosure of HIV status Lusaka,
in Zambian adolescents with HIV Infection Zambia

Hospital and Crossclinic
sectional

Children

127

Moodley et al.,

Paediatric HIV disclosure in South Africa  Cape Town,

Hospital

Caregivers

174

2006

caregivers’ perspectives on discussing HIV

Qualitative

South Africa

1115 years; Mean
12.4 (1.4)
011 years; median:

9% overall; 26% in

3.3

children older than 6

with infection children
Myer et al., 2006

Healthcare providers’ perspectives on

years
Cape Town,

Hospital

Qualitative

discussing HIV status with infected children South Africa
Oberdorfer et al., Disclosure of HIV/AIDS diagnosis to HIV-

Northern

2006
Petersen et al.,

infected children in Thailand
Psychosocial challenges and protective

Thailand
Durban,

influences for socio-emotional coping of

South Africa

2010

37.8%

Health

40

Not reported

N/A

103

616 years; mean: 9.5

30%

1416 years

N/A

N/A

professionals
Hospital

Cross-

Hospital

sectional
Qualitative

Caregivers
Children,

40 (25 children,

caregivers

15 caregivers)

Children,

69 (34 children,

816 years; mean:

caregivers

35 caregivers)

12.5 (2.2)

HIV adolescents in South Africa: a
qualitative investigation
Punpanich et al.,
2008

Understanding the psychosocial needs of

Bangkok,

HIV-infected children and families: a

Thailand

Hospital

Qualitative

qualitative study
Schaurich, 2011

Disclosure of AIDS diagnosis to children
from the family members’ perspective

Porto Alegre,
Brazil

Clinic

Qualitative

*Vaz et al., 2008

The process of HIV status disclosure to HIV- Kinshasa, DRC Clinic

Qualitative

positive youth in Kinshasa, DRC
Vaz et al., 2010

Telling children they have HIV: lessons

Kinshasa, DRC Clinic

Qualitative

learned from findings of a qualitative study

Caregivers

7

Not reported

N/A
N/A

Children,

40 (19 children,

1021 years; mean:

caregivers

21 caregivers)

16.1

Caregiver-child

16 (7 children,

817 years

dyads

9 caregivers)

In recruitment,
screened 259 children

in Sub-Saharan Africa

and 8 (3%) had been
told their HIV status

Vaz et al., 2011

Patterns of Diagnosis Disclosure of HIV
Status to Infected Children in a SubSaharan African Setting

Kinshasa, DRC Clinic

Qualitative

Caregivers

201

517 years; median: 8

N/A
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Caregivers, health

health professionals)

Qualitative

professionals

42 (21 caregivers, 21 Not reported

N/A

sampling methods and scientific design to estimate disclosure prevalence and were not designed to evaluate the
impact of disclosure. Most studies reporting disclosure
prevalence were cross-sectional in design and employed
non-randomized, small, convenience samples of various age
ranges of children and adolescents.

*Articles describe the same study population.

clinic staff

 a qualitative study of caregivers and

South Africa

Clinic
treatment among children in South Africa Province,

well-being, and social relationships in a
resource-limited setting

antiretroviral therapy adherence, child

Factors influencing uptake of HIV care and Gauteng
Yeap et al., 2010

1.7%
014 years; mean: 6.8
120
Caregivers
Qualitative
Hospital
Kenya

Western
The perceived impact of disclosure of

pediatric HIV status on pediatric
2010

Vreeman et al.,

Proportions of

disclosed children
Study

Table 1 (Continued )

Title

Location

Setting

Study design

Population

Sample size (N)

Children’s age range
and/or mean or

median age (SD)
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Factors influencing paediatric HIV disclosure
Studies identified multiple factors influencing whether disclosure occurred, many of which were described through
qualitative inquiry. Most factors shaping disclosure were at the
level of the child or the caregiver (Table 2). Child characteristics
considered important to disclosure included the child’s
age [17,25,3133,3642,44,45,51,53,54,58], gender [46],
education level [36,39,42,59], medication responsibilities
[36], whether the child asks questions [35,37,41,42,51,55,56],
and their perceived ability to understand their diagnosis
[37,39,40,44,46,47,51,53,54]. The prevalence of disclosure
varied most dramatically based on the age of the population,
with most children not knowing their HIV status until older
ages. For example, in a sample of 492 HIV-infected children in
South Africa, 3% of four- to six-year olds knew their status,
compared to 17% of seven- to ten-year olds and 77% of those
aged 11 years and older [48]. The child’s clinical status [32] also
influenced disclosure. Receiving ART [31,59], a longer duration
of enrolment in clinic or on ART [36,59] and the child having a
lower CD4 count [25] were associated with a greater likelihood
of disclosure.
The characteristics and beliefs of the caregiver further
shaped whether and how disclosure took place (Table 2).
Caregivers were more likely to disclose if they had a higher
level of education [44,46,59] or were more open about their
own HIV infection [31,38,40,53]. Caregivers with financial
problems [25] and caregivers who were not the father or
who were parenting in a context where the father had
died [25,36] were also more likely to have disclosed. The
caregiver’s beliefs about children’s ability to understand or
about the impact of disclosure further influenced disclosure
[32,37,41,43,44,53,56,58]. Variations in disclosure patterns by
children’s gender were not reported in studies identified in
this review.
Studies described both barriers preventing the disclosure of
HIV status to children in resource-limited settings and
potential advantages to disclosure (Table 3). Numerous fears
on the part of caregivers and healthcare providers were cited
as barriers to disclosure. These included fear the child would
disclose to others [25,32,3538,42,44,45,49,5155,59], fear
of subsequent stigma or negative effects from others knowing
the diagnosis [25,32,35,37,44,47,49,51,52,5456,59], concerns for worsening the child’s emotional or physical health
[25,32,36,38,4145,47,51,5356,59], believing the child is
unready or too young [25,3537,39,4345,47,5155,59],
feeling unprepared for questions or the disclosure process
[43,5356] and fear of the children’s resentment [25,45,53,
54,56,59]. In a survey of Nigerian caregivers’ reasons for nondisclosure, caregivers reported fears of the child subsequently
telling other children (41%) or family and friends (33.7%),
concerns the child was too young to understand (63%),
fears the parents would be blamed (26.5%) and fears of
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Table 2. Child and caregiver factors influencing disclosure
Characteristics of the
child influencing
disclosure
Child’s age

Description of child-related factors


More likely to disclose if child is older (Bhattacharya et al., 2010; Biadgilign et al., 2011; Boon-Yashidi et al., 2005;
Brown et al., 2011; Corneli et al., 2009; Demmer, 2011; Ferris et al., 2007; Kouyoumdjiam et al., 2005; Menon
et al., 2007; Petersen et al., 2010; Schaurich, 2011; Vaz et al., 2008; Vaz et al., 2010; Vaz et al., 2011; Vreeman
et al., 2010).



Child’s level of maturity/
awareness

In multivariate analysis, child’s older age was predictor of disclosure (Kallem et al., 2010; Oberdorfer et al.,
2006).



Caregivers felt mid-teenage years are appropriate time for disclosure (Arun et al., 2009).



Caregivers gave median age of 12 years as best age to disclose (Moodley et al., 2006).



Majority of providers stated 10 years as best age to disclose (Myer et al., 2006).



Varying understanding of illness and therapy over developmental course (Abadia-Barrero and Larusso,
2006).
k

Children B6 years exhibit little understanding of medication and sickness. Unlikely to disclose to them.

k

Children 79 years perceive negative connotation with sickness and/or AIDS.

k

Preadolescents have increased awareness of AIDS stigma and negative social values.

k

Adolescents very aware of negative social view of AIDS, but poor understanding of implications of infection.
Exhibit cynicism towards HIV-related care (Abadia-Barrero and Larusso, 2006).




More likely to disclose if child perceived as being aware of caregiver’s illness (Biadgilign et al., 2011).
Disclosure when children have emotional maturity and intellectual capacity (De Baets et al., 2007; Vreeman
et al., 2010).



Disclosure when child able to understand (Demmer, 2011).



Advocate disclosure if child able to understand concept of health, disease, and more complex concepts of chronic
illness (Myer et al., 2006).

Child asks questions
about health, disease
or HIV
Child’s family situation

Child’s inquisitive or persistent questions makes disclosure more likely (Hejoaka, 2009; Kouyoumdjiam et al., 2005;
Marques et al., 2006; Schaurich, 2011; Vaz et al., 2010; Vaz et al., 2011; Vreeman et al., 2010).



In multivariate analysis, child having a deceased biological father was a predictor of disclosure (Kallem et al.,
2010).



In multivariate analysis, child not having biological father as main caregiver was a predictor of disclosure
(Oberdorfer et al., 2006).



Caregivers felt disclosure was easier if they were also HIV positive and could show the child that it was possible
to have HIV and be healthy (Petersen et al., 2010).



Sense of concealment within the family: pervasive secrecy may create worry for child and facilitate disclosure
(Punpanich et al., 2008).

Education/school factors




Enrolment in school increased the likelihood of disclosure. (Bhattacharya et al., 2010; Myer et al., 2006).
In multivariate analysis, higher level of education of the child was a predictor of disclosure. (Kallem et al.,
2010).

Child going to school given as a reason causing caregivers to think more about disclosing (Vaz et al., 2011).
Health-related factors



Caregivers report disclosing based on child’s health status (Correction pendingneli et al., 2009; Vaz et al.,
2008).



Increased likelihood of disclosure was associated with increasing duration since HIV diagnosis and ART initiation
and non-perinatal mode of transmission (Bhattacharya et al., 2010).



In multivariate analysis, self-administration of HIV medication, longer time on ART, and longer time attending
clinic were predictors of disclosure (Kallem et al., 2010).



Disclosure more likely if child on ART (Menon et al., 2007).



In multivariate analysis, child having most recent CD4  15% was associated with increased disclosure
(Oberdorfer et al., 2006).
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Table 2. (Continued)
Characteristics/beliefs of
the caregiver influencing
disclosure
Feel worried about or

Description of caregiver-related factors


Caregiver beliefs that they are unprepared for questions and process make disclosure difficult (Abadia-Barrero
and Larusso, 2006; Boon-Yashidi et al., 2005; Demmer, 2011; Kouyoumdjiam et al., 2005; Marques et al., 2006;
Punpanich et al., 2008; Schaurich et al., 2011; Yeap et al., 2010).

unprepared for
disclosure


Caregiver anxiety over disclosure process prevents disclosure (Demmer, 2011).



Caregivers believe that they do not know enough about HIV to be able to explain/answer questions prevents
disclosure (Kouyoumdjiam et al., 2005).



Caregivers feel challenged by disclosure emotionally and psychologically; find subject painful and feel not
courageous enough to disclose (Kouyoumdjiam et al., 2005).



Fear negative effects of
disclosure





Caregivers uncertain how to engage in disclosure process (Punpanich et al., 2008).
Caregiver beliefs that disclosure will cause suffering for the child prevent disclosure (Abadia-Barrero and Larusso,
2006).
Caregiver fears of stigma, abandonment, and negative reaction of family and partners prevent disclosure
(Demmer, 2011).



Caregivers’ fears of shame and stigma prevent disclosure (Bhattacharya et al., 2010; Biadgilign et al., 2011;
Boon-Yashidi et al., 2005; Corneli et al., 2009; Demmer, 2011; Fetzer et al., 2011; Hejoaka, 2009; Kouyoumdjiam
et la, 2005; Marques et al., 2006; Oberdorfer et al., 2006; Punpanich et al., 2008; Schaurich, 2011; Vreeman et al.,
2010).



Caregiver fears child will tell others and face discrimination (Abadia-Barrero and Larusso, 2006; Bhattacharya
et al., 2010; Biadgilign et al., 2011; Boon-Yashidi et al., 2005; Brown et al., 2011; Corneli et al., 2009; Fetzer et al.,
2011; Hejoaka, 2009; Kallem et al., 2010; Kouyoumdjiam et al., 2005; Moodley et al., 2006; Oberdorfer et al.,
2006; Punpanich et al., 2008; Schaurich et al., 2011; Vaz et al., 2008; Vaz et al., 2011; Vreeman et al., 2010).



Caregivers’ beliefs that knowing status would create emotional stress, sadness or depression for the child prevent
disclosure (Abadia-Barrero and Larusso, 2006; Bhattacharya et al., 2010; Biadgilign et al., 2011; Boon-Yashidi
et al., 2005; Brown et al., 2011; Corneli et al., 2009; Demmer 2011; Kallem et al., 2010; Marques et al., 2006;
Moodley et al., 2006; Oberdorfer et al., 2006; Schaurich, 2011; Vaz et al., 2008; Vaz et al., 2010; Vaz et al., 2011;



Vreeman et al., 2010; Yeap et al., 2010).
Caregivers’ beliefs that knowing diagnosis would cause illness to progress more rapidly and/or ART can make
people sicker prevent disclosure (Yeap et al., 2010).

Belief in keeping HIV



Majority of caregivers do not believe in openly discussing HIV and believe status should be concealed (AbadiaBarrero and Larusso, 2006).

concealed/private


Caregivers believe in keeping diagnosis secret and do not trust that children can keep diagnosis from others
(Fetzer et al., 2011).

Other caregiver/family-



Higher education status of caregiver associated with higher likelihood of disclosure (Bhattacharya et al., 2010;



Biadgilign et al., 2011).
Caregivers who had discussed their own infection with their child were seven times more likely to have disclosed

related factors

(Moodley et al., 2006).


Disclosure was more likely if there were household financial problems (Oberdorfer et al., 2006).



Disclosure was more likely if caregiver was HIV-infected (Petersen et al., 2010).

psychological disturbance for the child (31%) [45]. Caregivers
more often expressed fears of stigma and the child telling
others, whereas healthcare providers focused more on
children’s emotional or physical health and age.
The most common reasons cited as advantages to disclosure were potential improvements in medication adherence [25,30,32,34,36,41,42,45,4952,56,59] and improving
the child’s care or treatment [17,25,32,3436,38,41,42,
51,52,54,56,59]. The child’s increasing age [32,33,36,39,41,
42,54,58,59], being able to answer the child’s questions

[3537,41,45,52,54,56,59], fulfilling the child’s right to know
[32,38,59] and equipping the child to protect others or
themselves [36,41,42,54,56,59] were also cited by caregivers
as reasons to disclose to children.
Process of paediatric HIV disclosure in resource-limited
settings
While some studies described disclosure as a one-time
event, during which a child was told the reason they were
taking medicines or was told the name of their diagnosis
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Table 3.

Barriers and advantages of disclosure
Concern for child’s

Barriers to
disclosure
Studies

Fear child will tell
others

Subsequent stigma

Abadia-Barrero and

Unpreparedness for
Believing child
unready or too young

Abadia-Barrero and

Bhattacharya et al.,

Larusso, 2006*
Bhattacharya et al.,

2010
Larusso, 2006*
Larusso, 2006*
Biadgilign et al., 2011 Bhattacharya et al., 2010 Bhattacharya et al.,

2010
Biadgilign et al., 2011 Boon-Yashidi et al.,

Biadgilign et al., 2011

Abadia-Barrero and

questions or disclosure
process
Abadia-Barrero and
Larusso, 2006*
Boon-Yashidi et al., 2005*

2010
Biadgilign et al., 2011 Demmer, 2011*

Boon-Yashidi et al.,

2005*
Corneli et al., 2009;

Boon-Yashidi et al., 2005* Boon-Yashidi et al.,

2005*
Brown et al., 2011
Corneli et al., 2009;

Vaz et al. *2008
Demmer, 2011*
Fetzer et al., 2011*

2005*
Brown et al., 2011
Demmer, 2011*

Marques et al., 2006*
Punpanich et al., 2008*

Vaz et al., 2008*
Fetzer et al., 2011*
Hejoaka, 2009*

Vaz et al., *2008
Hejoaka, 2009*
Demmer, 2011*
Kouyoumdjiam et al., Kallem et al., 2010

Hejoaka, 2009*
Kallem et al., 2010

Schaurich, 2011*
Yeap et al., 2010*

Kallem et al., 2010

2005*
Marques et al., 2006* Marques et al., 2006*

Brown et al., 2011
Corneli et al., 2009;

Kouyoumdjiam et al., Oberdorfer et al.,

Moodley et al., 2006*

2005*
2006
Moodley et al., 2006* Punpanich et al.,

Oberdorfer et al., 2006

Oberdorfer et al.,

Oberdorfer et al.,

2008*
*Schaurich, 2011*

Schaurich, 2011*

2006
Punpanich et al.,

2006
Punpanich et al.,

Vreeman et al.,

Vaz et al., 2010*

2008*
Schaurich, 2011*

Advantages of
disclosure
Improving adherence

Improving child’s
care or treatment

Vaz et al., 2011*
Vreeman et al., 2010*
Yeap et al., 2010*
Providing answers to
child’s questions

Kouyoumdjiam et al., 2005*

Kouyoumdjiam et al.,
2005*
Myer et al., 2006*

2008*
2010**
Schaurich, 2011*
Vaz et al., 2011*
Vreeman et al., 2010*

Studies

emotional or physical
health

Vreeman et al., 2010*
Yeap et al., 2010*
Fulfilling child’s right Child being able to protect
to know
themselves or others

Bhattacharya et al.,

Bhattacharya et al.,

Bhattacharya et al., 2010 Bhattacharya et al.,

Bhattacharya et al., 2010

2010
Biadgilign et al.,

2010
Biadgilign et al.,

2010
Boon-Yashidi et al., 2005* Corneli et al., 2009;

Boon-Yashidi et al., 2005*

*2009
Bikaako-Kajura

2009*
Boon-Yashidi et al.,

Brown et al., 2011

et *al., 2006
Brown et al., 2011

2005*
Corneli et al., 2009;

Hejoaka, 2009*

Marques et al., 2006*

Corneli et al., 2009;

Vaz et al., *2008
Ferris et al., 2007

Kallem et al., 2010

Vaz et al., 2010*

Vaz et al., *2008
Fetzer et al., 2011*

Hejoaka, 2009*

Kouyoumdjiam et al.,

Vaz et al., 2011*

Vaz et al., *2008
Moodley et al., 2006* Kallem et al., 2010

2005*
Haberer et al., 2011 Kallem et al., 2010
Marques et al., 2006*
Kallem et al., 2010
Marques et al., 2006* Punpanich et al., 2008*
Marques et al., 2006* Moodley et al., 2006* Vaz et al., 2010*
Oberdorfer et al.,
Oberdorfer et al.,
2006
Punpanich et al.,

2006
Punpanich et al.,

2008*
Vaz et al., 2010*
Vaz et al., 2011*
Vreeman et al., 2010*

2008*
Vaz et al., 2010*
Vaz et al., 2011*
Vreeman et al., 2010*

*Denotes qualitative study design.
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[25,41,44,53,58,59], other studies described children experiencing partial disclosure before being told they had HIV
[30,42,46,55,56]. In several studies, caregivers reported lying
to the children about the reason for taking their medicines
until after full disclosure [25,42,51,58,59]. This contrasted
with the emphasis from disclosed adolescents in Brazil on the
importance of children’s receiving accurate and complete
information about HIV [56]. Vaz et al. included a more
detailed description of the disclosure process for children in
the Democratic Republic of Congo (DRC), where disclosure
included giving minimal information about the illness itself,
but featured discussion of the medications [33,41]. While
caregivers typically conceptualized disclosure as a process,
children described disclosure as a discrete event rather than
a process, with limited conversations with caregivers and
healthcare providers before, during or after disclosure [41].
Parents also described preparatory activities around the day
of disclosure, including preparing the child’s favourite foods,
offering gifts and making sure the child felt loved [33]. In
Thailand, caregivers reported that most disclosure events
occurred when children were sick and alone with caregivers
(89.2%) [25].
Studies endorsed involving both healthcare professionals
and the child’s parents or caregivers in disclosure. In a
majority of studies, caregivers were thought to be the best
people to carry out the disclosure process or were reported as
the primary discloser [25,30,3639,41,45,54,58,59]; however,
some caregivers wanted healthcare providers to lead disclosure [36,44,57] or preferred that healthcare providers
partnered with the child’s caregiver [38,39]. In a study from
Zimbabwe, 51.3% of caregivers wanted healthcare workers
involved with disclosure and 42.3% wanted help from another
family member such as a sister or parent [46]. Marques et al.
reported several instances in which healthcare providers
disclosed to children without prior consultation with caregivers who believed their child was not ready or that
disclosure by providers was conducted inappropriately [56].
Opinions about the optimal age for disclosure varied. In
one study from South Africa, healthcare providers believed
six years was appropriate for a general discussion about
health issues and ten years was appropriate for HIV-specific
disclosure [39]. Caregivers from South Africa endorsed older
ages for both events  11 years for a general discussion and
12 years for HIV-specific information [38]. In Zimbabwe,
community members preferred full disclosure at 1415
years, with partial disclosure at 1011 years, but healthcare
providers preferred younger ages [46]. The caregivers’
preferences generally matched the age at which disclosure
was actually done. In Thailand, one study found that being
over 10 years was associated with knowing your HIV status
[25], and in a small study from the DRC, the median age for
disclosure was 15 years, with no children under ten years
having been informed of their status; however, only 19
children were included in the study [33]. Two studies
reported on caregivers’ and healthcare providers’ desire for
protocols, materials or specific guidelines to direct disclosure
[37,39].

Impact of disclosure on children and caregivers
Fourteen studies discussed the impact of disclosure on HIVinfected children; however, no studies evaluated children
pre- and post-disclosure [17,25,3032,35,40,41,43,45,49,
50,56,57] (Table 4). The experience of disclosure on children
in resource-limited settings was reported through qualitative
or descriptive studies, in which disclosure was described as
a positive event among the majority of those who went
through it [32,56,57]. In Brazil, adolescents characterized
disclosure as an essential step in adapting to a ‘‘normal’’ life
with HIV and thought disclosure should be done as soon as
possible [56]. Among Thai youth aged 1316 years, 33.3%
reported wishing they had been told sooner or much sooner,
and 79.6% were satisfied with disclosure process; however,
18.5% wished they had not been told of the diagnosis at
all [57].
The combined evidence from this review suggests that
disclosure may play an important role in improving medication adherence and HIV-related outcomes. Four qualitative
studies reported adherence improved post-disclosure
[30,32,35,49]. In Burkina Faso, youth reported that disclosure
enabled them to maintain their HIV treatment, including
their ability to conceal the diagnosis from others [35]. As one
youth in the DRC described regarding improved adherence:
‘‘Having heard explanations made it easy for me to take the
medicines. I was told what medicines do in my body. That
is why I take them’’ [49]. Two studies attempted to quantify
changes in adherence post-disclosure [45,50]. In a study from
Nigeria, among caregivers who had disclosed to children,
64% felt that adherence had improved post-disclosure [45]. A
study of paediatric ART adherence in Zambia found that the
average number of missed ART days was 38% lower among
children who knew their status (p0.001) [50]. Though
knowledge of HIV status was strongly associated with age, it
remained an independent predictor for adherence when
adjusted for age [50]. A study of 325 HIV-infected children in
Romania found that disclosed children were less likely to
experience disease progression (p0.03), as measured by
CD4 count or death [17].
Evidence on the emotional and psychological impact of
disclosure was more limited. In the only study identified that
quantified the psychological differences between disclosed
and non-disclosed children, univariate analysis of 127
children in Zambia found non-disclosed children were more
than twice as likely to experience concerning levels of
emotional difficulty (OR 2.62, 95% CI: 1.116.26) [31]. In
qualitative studies, many youth reported initial emotional
difficulties, some of which were mitigated over time. In a
qualitative study of 25 South African adolescents, almost all
found disclosure to be emotionally difficult [40]. In Brazil and
the DRC, children reported feeling sadness, grief, and worry
upon learning about their HIV infection, but these negative
feelings were followed by some feelings of relief [33,41,56].
Congolese children reported feeling calmer after disclosure
because knowing their HIV status removed some of the
uncertainty surrounding their illness [32]. Despite the
negative emotions of sadness and worry, a number of studies
reported that children felt that knowing HIV status was
important and necessary [33,41,56].
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Table 4.

Impact of disclosure

Study
Bikaako-Kajura et al.,
2006*

Impact of disclosure on children
Described improved adherence; disclosure believed to be motivating factor because child understood importance of
medication; more positive attitude towards treatment; developed own adherence strategies and/or shared
responsibility for treatment.

Brown et al., 2011

Caregivers reported improved adherence in 66% of children.

Corneli et al., 2009;

Improved adherence; knowledge of diagnosis improved adherent behaviours; better able to protect themselves and

Vaz 2008*

others; some youths expressed emotional difficulties from disclosure, including sadness, discouragement and fear.

Ferris et al., 2007
Fetzer et al., 2011*

Significantly more frequent CD4 counts; significantly less likely to experience disease progression and death.
Less frustration with medication-taking; disclosure as a motivating factor for adherent behaviours.

Haberer et al., 2011

Significantly fewer missed ART days (compared to undisclosed children).

Hejoaka, 2009*

Improved adherence; children maintained concealment strategies and secrecy.

Lee and Oberdorfer,

Majority viewed disclosure as a positive event.

2009*
Marques et al., 2006*

Majority viewed disclosure as a positive event; adolescents felt disclosure had positive long-term psychological
impacts and allowed for better self-care and treatment.

Menon et al., 2007
Oberdorfer et al., 2006
Petersen et al., 2010*

Significantly fewer emotional difficulties (compared to undisclosed children).
Majority of children accepted diagnosis; some reported sadness, anger and rebellion.
Negative effects and emotional difficulties included: distress, fear, perceived stigma, internalized stigma, withdrawal
from peers, and perceived shortened future. Accepting family social support helped to address these challenges.

Vaz et al., 2010*

Negative effects and emotional difficulties included: sadness, worry and perceived stigma; some children reported
relief after disclosure and felt disclosure was important.

*Denotes qualitative study design.

Completing child disclosure also impacted caregivers differently. Some caregivers reported feeling relieved and happy
with their decision to disclose [32,56]. Caregivers appreciated
sharing the responsibilities of adherence with the child after
disclosure [30], and described having less frustration with
adherence [49]. Other caregivers reported negative emotional
effects after disclosing, such as feeling unprepared for
answering children’s continuing questions and fear that social
stigmatization might result if the child told others [41,56]. No
studies measured actual experiences of stigma, discrimination, or social rejection post-disclosure for caregivers or their
children. The systematic review found no studies that reported
on the impact of disclosure on adolescent sexual behaviours
or risk reduction for secondary transmission.

Discussion
In resource-limited settings, the prevalence of HIV disclosure
to children is generally low, even among adolescents.
Significant factors influencing disclosure include the child’s
age, the child’s persistent questioning and caregivers’
perceptions of the child’s ability to understand and cope
up with HIV. Caregivers identify many barriers to disclosure
within these settings, the most prominent being fear of
stigma and of negative consequences for children’s emotional and social well-being. In the midst of caregivers’
worries about disclosure and low prevalence of disclosure,
there is only limited evidence to suggest how disclosure will
impact children. Some studies assessing children who know
their HIV status describe possible improvements in children’s
medication adherence and emotional health, but other
studies describe negative effects. Because the impact of

disclosure on children has rarely been assessed quantitatively, research to evaluate how disclosure impacts children’s
physical, emotional, mental, and social outcomes would
improve implementation of age- and culture-appropriate
disclosure.
Much of the work assessing disclosure to HIV-infected
children in resource-limited settings is qualitative in nature
and provides a useful body of literature describing important
cultural concepts shaping when, how, and whether children
are informed of their HIV status. Reasons given by caregivers
for and against disclosure are similar across resource-limited
and resource-rich settings with potential benefits weighted
against potential harms of disclosure. While the child’s age,
developmental maturity, and concerns about medication
adherence can drive parents and caregivers towards telling
the child about their HIV diagnosis, deep-seated fears of the
child telling others about the diagnosis and of potential
negative emotional consequences for the child also shape
caregivers’ decisions about disclosure. As HIV care programmes attempt to engage in disclosure for their growing
populations of children, caregivers’ fears of stigma and
negative psychosocial effects need to be addressed with
appropriate disclosure protocols and procedures.
Learning about their HIV status is clearly an emotional
and pivotal point in a child’s life. Children describe reacting
with sadness and grief, as well as anxiety and worry about
what their diagnosis means for the future. In addition,
children share their caregivers’ worries about the negative
social repercussions that may result if their HIV status is
revealed to others. No studies investigated whether fears of
stigma translated into actual discrimination post-disclosure.
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In qualitative studies, disclosure is often described as a
positive event, and at least one quantitative study suggested
that, despite the immediate burden of learning one’s HIV
diagnosis, disclosed children actually have better emotional
health outcomes compared to their non-disclosed counterparts. Limited evidence also suggests disclosure is associated
with better adherence to ART and HIV-related health outcomes, although the effect of disclosure on adherence could
not be evaluated.
The compiled evidence of this review suggests that there
may be both positive and negative effects from disclosure.
Additional qualitative and quantitative studies are needed to
investigate how disclosure impacts children, particularly their
adherence to ART, and physical, emotional, and social
outcomes. Providing appropriate resources and support to
caregivers and children through the disclosure process may
mitigate any potential negative effects of disclosure. Furthermore, effective strategies to assess and monitor children’s
clinical and psychosocial well-being throughout the process
will also help ensure that children and caregivers receive
necessary services. While a number of web-based resources
for disclosure exists [28,60,61], their impact has not been
evaluated rigorously and merits attention. Investigating how
the existing disclosure protocols and procedures may be
cross-culturally adapted also deserves further consideration.
There are several limitations to this systematic review that
warrant consideration. We may have failed to identify
publications from non-traditional or non-Western literature
sites, but we attempted to follow the most inclusive and
systematic methodology readily available. Few non-English,
French, Spanish or Portuguese studies were identified.
Publication bias could be a concern; however, we were
encouraged by the recent increase in studies from low- and
middle-income countries, with all included studies having
been published since 2004. In addition, we opted to include
only published studies, as the quality of the existing studies
was already fraught with limitations. While few studies
measured the prevalence of disclosure or the quantitative
impact of disclosure, the current understanding of disclosure
in these settings is such that qualitative work is critically
needed to understand cultural phenomena. The studies were
heterogeneous, with inconsistent definitions or processes for
disclosure, and few quantitative data about factors related to
disclosure. Thus, we could not conduct a meta-analysis at this
time for factors related to disclosure or a pooled estimate for
the impact of disclosure. Key factors shaping the disclosure
process may still be missing from these compiled data. For
example, government policies and guidelines in different
countries may have legal implications for disclosure. The
studies that we summarized did not specifically include
discussions of national laws and policies regulating disclosure
in particular settings, which may influence the age for
disclosure and who can be involved. Studies were also
heterogeneous in the ages of study participants, with some
studies including only children, others only adolescents, and
many including both children and adolescents. Important
differences in how disclosure takes place as well as its impact
on clinical, emotional, and social outcomes for children and
adolescents may be present; however, this review did not

investigate this aspect of disclosure because of the limited
body of data. Similarly, differences in disclosure patterns by
gender could not be assessed in this review. Finally, we
excluded studies reporting only on parents’ disclosure of their
own HIV status to children or on youth disclosure of their
own status to other people. Although these types of
disclosure also merit careful consideration, the motivations
and potential impacts may be different.

Conclusions
This systematic review revealed the paucity of data related to
disclosure of HIV status to children in low- and middleincome countries. While specific evidence-based recommendations for how and when disclosure should take place are
premature, the findings of this review and from the more
robust literature available from the United States allow us to
make preliminary recommendations for disclosure to children
in resource-limited settings and directions for future research. First, disclosure needs to be addressed thoughtfully
and proactively as part of long-term disease management.
This includes consideration of cultural views about a child’s
age, maturity level and emotional health and addressing
families’ widespread fears about potential HIV-related stigma
and discrimination if their child’s status is revealed to others.
These concerns suggest that improved psychosocial support
services in these settings could aid in the disclosure process.
Second, there is a need for structured, evidence-based
protocols, materials and guidelines for paediatric HIV disclosure that have been rigorously evaluated and incorporate
both preparation and on-going communication among
children, caregivers and health providers. Existing materials
on disclosure should be made available for adaptation,
evaluation and broader implementation. Finally, additional
research is needed on effective strategies for disclosure
and the clinical, emotional and social impact of disclosure on
HIV-infected children in resource-limited settings. Longitudinal studies that follow children through the disclosure
process will be better able to assess the impact of disclosure
and allow clinicians and other providers to deliver appropriate services and support to children and caregivers.
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